Table:
begin	end	state
1	5	non-cytoplasmic
6	30	transmembrane
31	68	cytoplasmic
69	87	transmembrane
88	92	non-cytoplasmic
93	116	transmembrane
117	141	cytoplasmic
142	161	transmembrane
162	176	non-cytoplasmic
177	196	transmembrane
197	205	cytoplasmic
206	227	transmembrane
228	235	non-cytoplasmic
236	257	transmembrane
258	295	cytoplasmic
296	318	transmembrane
319	363	non-cytoplasmic
364	384	transmembrane
385	395	cytoplasmic
396	417	transmembrane
418	422	non-cytoplasmic
423	445	transmembrane
446	489	cytoplasmic

Input:
>WP_057687367.1 NCBI__GCF_001431535.1:WP_057687367.1
MNIESIVGAIVAIVWSPYLVALCLLGGLYFSIRTRFIQLRALPEMLRLMFKHRASESGLS
PFQALNISLSSRVGVGNIAGVAMAIAFGGPGAIFWMWVVAFFGASSAFVESTLAQIYKQR
DAQGQYRGGPAYYMEKGLGQRWYAVIFAICTVAAAAMLAGTQSNAIASALHEAWDLPVHA
SAVGVVLLLALIIFGGVRRIAAVTQWIVPLMATAYLLVALVVMLLSYERIPEVLSLIMRS
AFGLDATFGAMIGVAIQWGVRRGVLSNEAGMGSGAHPAAAAEVSHPVKQGLVQAFSVYID
TMVVCSATAFLILSTGMYNVYDPAVNGVPDQARMLLDNLPGMEAGPRFVQHAVESALPGF
GKSFVALAILPFAFTTILALYYMGDTNVSYLCRDKPAAWIVNVFRVLFLALAAYSAINSA
TLAWTLGDIGVGMMSWLNIIAILLLHKPALAALRDYETSRKAGIDPVFEPDRLGIKGASL
WNRITKAIG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server